精神分裂症研究中的卫生经济措施。
Health economic measures in schizophrenia research.
作者信息
McCrone Paul
机构信息
Department of Health Service and Population Research, King's College London, Institute of Psychiatry, UK.
出版信息
Br J Psychiatry Suppl. 2007 Aug;50:s42-5. doi: 10.1192/bjp.191.50.s42.
BACKGROUND
It is essential in economic evaluations of schizophrenia interventions that all relevant costs are identified and measured appropriately. Also of importance is the way in which cost data are combined with information on outcomes.
AIMS
To examine the use of health economics in evaluations of interventions for schizophrenia.
METHODS
A review of the key methods used to estimate costs and to linkcosts and outcomes was conducted.
RESULTS
Costs fall on a number of different agencies and can be short term or long term. Cost-effectiveness analysis and cost-utility analysis are the most appropriate methods for combing cost and outcome data.
CONCLUSIONS
Schizophrenia poses a number of challenges for economic evaluation.
背景
在精神分裂症干预措施的经济学评估中，识别并恰当衡量所有相关成本至关重要。成本数据与结果信息的结合方式也很重要。
目的
探讨卫生经济学在精神分裂症干预措施评估中的应用。
方法
对用于估计成本以及将成本与结果相联系的关键方法进行了综述。
结果
成本由多个不同机构承担，可能是短期的，也可能是长期的。成本效益分析和成本效用分析是整合成本与结果数据的最合适方法。
结论
精神分裂症给经济学评估带来了诸多挑战。
Zotero 插件